Healthcare News and Research

Latest Healthcare News and Research

Republicans schedule repeal votes to bring attention to health law

One of the highest profile efforts involves the repeal of the health law's medical device tax, and one proposal also includes language that would trim the measure's insurance subsidies for low- and middle-income taxpayers.

From Medtronic 5 Jun 2012

Fate of pre-existing condition insurance pools, health exchanges may hinge on high court ruling

News outlets report on what might become of programs such as high risk pools and health exchanges if some or all of the health law is overturned by the Supreme Court.

5 Jun 2012

Bloomberg's proposed super-size soda ban is latest attack on portion size in war against obesity

New York City mayor seeks to limit the size of sugary beverages but the plan draws scorn from the soft drink industry and heightens the debate about how involved government should be in efforts to "steer individual behavior in the name of health."

5 Jun 2012

HDL to offer testing services based on Critical Diagnostics' Presage ST2 Assay

Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases and Health Diagnostic Laboratory, Inc. (HDL, Inc.), announced today an agreement under which HDL, Inc. will soon offer ST2 testing services based on Critical Diagnostics' Presage ST2 Assay.

5 Jun 2012

Ways to improve care and reduce the high cost for Medicare beneficiaries highlighted by Hopkins study

It’s well known that a relatively small percentage of chronically ill patients account for a disproportionate amount of health care dollars. Now, a multicenter study led by Johns Hopkins researcher Bruce Leff, M.D., might provide insights into how to cut Medicare costs while improving health care for older adults suffering from chronic health conditions.

5 Jun 2012

Force 3 acquires secureRAD

Force 3, delivering innovative technology solutions, today announced the acquisition of secureRAD, a provider of disruptive technology solutions for the medical imaging industry.

5 Jun 2012

LifePoint to acquire Woods Memorial Hospital

The Woods Memorial Hospital Board of Directors today announced it has signed an asset purchase agreement for the acquisition of the hospital by LifePoint Hospitals, a leading hospital company focused on providing quality healthcare close to home.

5 Jun 2012

First Edition: June 4, 2012

Today's headlines include the latest news on implementation of the health law, on the pending Capitol Hill effort to repeal the medical device tax and reports from the states.

4 Jun 2012

Prisoners need education on the appropriate use of topical antibiotic products

Prisoners need education on the appropriate use of topical antibiotic products, according to a study released today at the 39th Annual Educational Conference and International Meeting of the Association for Professionals in Infection Control and Epidemiology.

4 Jun 2012

Study shows valuable role of Mammostrat in assessing ER+ postmenopausal breast cancer patients

GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology.

4 Jun 2012

Affibody, GE Healthcare partner to develop Her2-targeted PET imaging agent

GE Healthcare signed an agreement with Affibody AB to collaborate on the development of a Her2-targeted PET imaging agent, which is scheduled to begin clinical trials later this year.

4 Jun 2012

Socioeconomic status of patient linked to choice of treatment

Though it would seem logical, cancer patients don't always choose therapies with the best chance for survival-cost and side effects are also major considerations. Little has been known about the extent to which cost and side effects influence a patient's treatment decision. Now, new findings by Fox Chase Cancer Center researchers reveals that a patient's socioeconomic status, more than any other characteristic-such as age or disease site-is predictive of whether he or she will favor high efficacy, low cost or low toxicity when choosing a treatment.

2 Jun 2012

High costs can limit access to potentially life-saving technology

More than one-fifth of people who have received referrals to test for cancer-causing genes say they will only undergo testing if their insurance covers the cost-just as more insurers are instituting cost-sharing for medical services like genetic testing, according to new findings from Fox Chase Cancer Center in Philadelphia released at this year's 2012 Annual Meeting of the American Society of Clinical Oncology on Saturday, June 2.

2 Jun 2012

New assay to test for newborn exposure to designer stimulants

United States Drug Testing Laboratories, Inc, a reference laboratory specializing in alcohol and substances of abuse testing, released a new assay testing umbilical cord for newborn exposure in utero to Designer Stimulants/ Bath Salts on Friday, June 1, 2012. The CordStat® assay screens for the most common of designer stimulants known as "Bath Salts."

2 Jun 2012

Global generic pharmaceuticals market to reach $231.00 billion in 2017 at 9.29% CAGR

The global generic pharmaceuticals market is likely to witness strong growth in the next few years owing to the patent expiration of key blockbuster drugs and the judicious cost containment efforts of governments and healthcare service providers worldwide.

2 Jun 2012

HealthSouth to build comprehensive physical rehabilitation hospital in greater Orlando

HealthSouth Corporation today announced it has received permission from the state to proceed with building a comprehensive physical rehabilitation hospital in the greater Orlando, Fla., market. The 50-bed hospital will provide comprehensive physical rehabilitation to patients who have experienced stroke, trauma, brain and orthopedic injuries or other major illness or injuries.

2 Jun 2012

Expanding role of modeling and simulation across drug development lifecycle

Quintiles today issued the first of three white papers on the expanding role of modeling and simulation across the drug development lifecycle. "Lifecycle Modeling and Simulation: Current Practice and Future Impact on Healthcare Innovation and Delivery" discusses the potential of modeling and simulation to advance healthcare delivery through applications in drug development.

2 Jun 2012

Lilly launches clinical trial mobile app for oncology healthcare professionals

Today, Eli Lilly and Company launched a searchable clinical trial mobile application for oncology healthcare professionals.

2 Jun 2012

HNC patients may be at increased risk for post-treatment side effects

New data from an Internet-based study show that patients with head and neck cancers (HNC) may be at risk for significant late effects after their treatment, but they're unlikely to discuss these and other survivorship care issues with their doctors.

2 Jun 2012

America's biopharmaceutical researchers work on many new approaches to fight cancer

America's biopharmaceutical research companies are testing 981 medicines and vaccines to fight the many types of cancer affecting millions of patients worldwide, according to a report released today by the Pharmaceutical Research and Manufacturers of America.

2 Jun 2012